Cancer World Newsletter - Radiotherapy capacity across Europe: what it should be, and what it is Print
How do you convince hard-pressed health authorities that it is worth investing in radiotherapy facilities?
Two initiatives that could help are examined in this Spotlight article. The first provides hard evidence
about the alarming variations in capacity across Europe, the other offers a model for assessing the cost
and cost-effectiveness of upgrading and expanding capacity.

What do you think?

  • Do governments/healthcare providers listen when a strong case is made for investing in badly
    needed facilities?
  • Should cost-effectiveness analysis be applied more widely to guide the way scarce health
    resources are spent?
 You can read the article here. Press the comment button at the end and share your views.